Breaking
Tuesday, July 7, 2026

News

🇪🇺 EMA Page 27

Latest pharmaceutical news, drug approvals, and EMA regulatory updates

Showing 313–324 of 341 articles

High impact NewsApr 15, 2026

MENA Medical Device Regulatory Training Course Launches May 2026 to Address Growing Market Demand

2 min

Prof. Marcus Webb
High impact NewsApr 15, 2026

CMO/CDMO Market to Reach $5.46 Billion by 2035 as Biologics Manufacturing Outsourcing Accelerates

2 min

Prof. Marcus Webb
High impact NewsApr 15, 2026

New Clinical Trial Monitoring Course Addresses Rising GCP Compliance Issues in Biopharmaceutical Industry

2 min

Prof. Marcus Webb
High impact NewsApr 15, 2026

New GCP Inspections Training Course Addresses ICH GCP E6(R3) and EU CTR Compliance for Pharmaceutical Companies

FDA · 2 min

Prof. Marcus Webb
High impact NewsApr 15, 2026

Vabysmo Market Report 2026: Roche's Eye Drug Shows Strong Growth Through 2035 Amid Rising Retinal Disorder Cases

2 min

Dr. Elena Rossi
High impact NewsApr 15, 2026

GlycoNex GNX1021 Gets PMDA Approval for First-in-Human Phase 1 Trial in Gastrointestinal Cancers

PMDA · 2 min

Dr. Elena Rossi
Standard impact NewsApr 13, 2026

EMA AI System for Faster Drug Safety Signal Detection

EMA · Pharmacovigilance · 6 min

Dr. Elena Rossi
Standard impact NewsApr 13, 2026

European Commission Blockchain Pilot Enhances Pharmaceutical Supply Chain Security

European Commission · 6 min

Dr. Elena Rossi
High impact NewsApr 11, 2026

EMA Conditional Approval CAR-T Therapy for Relapsed B-Cell Lymphoma

EMA · Oncology · 4 min

Dr. Elena Rossi
High impact NewsApr 11, 2026

EMA Issues Positive Opinion for Zepzelca (Lurbinectedin) in Cancer Treatment

EMA · 2 min

Dr. Elena Rossi
High impact NewsApr 11, 2026

EMA Backs Amgen's Tarlatamab as First-in-Class BiTE Therapy for Advanced Small Cell Lung Cancer

EMA · oncology · 3 min

Dr. Elena Rossi
High impact NewsApr 11, 2026

EMA Issues Positive Opinion for Adstiladrin Gene Therapy in Bladder Cancer Treatment

EMA · 2 min

Dr. Elena Rossi